Taken together, corroborating our animal studies, our human data highlight a pivotal role for Fyn/tau/NR2B/PSD95 interactions involving tau phosphorylation, Fyn/SFK and NMDAR activation in mediating seizures and disease-associated pathophysiological changes in epilepsy. The gene discussed is DLG4; the disease is epilepsy.